Related Experiment Video
Updated: Jun 26, 2026
10:28
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
Biomarkers for Parkinson's disease.
1The Athenaeum, Pall Mall, London SW1Y 5ER, UK. manuel@graeber.net
Experimental Neurology
|January 27, 2009
Summary
Researchers identified changes in alpha-synuclein expression in skin cells, suggesting a potential new biomarker for Parkinson's disease (PD) diagnosis. This finding could lead to objective diagnosis using accessible peripheral tissues.
Area of Science:
- Systems biology
- Genomics
- Biomarker discovery
Background:
- Parkinson's disease (PD) diagnosis relies on clinical symptoms, highlighting the need for objective biomarkers.
- Systems biology approaches investigate biological factors for early disease identification and risk assessment.
- Previous research identified metabolic dysregulation in PD, detectable through various bodily fluids.
Discussion:
- Hoepken et al. report on alpha-synuclein expression changes in skin fibroblasts.
- These expression changes may serve as a potential biomarker for objective PD diagnosis.
- Utilizing accessible peripheral tissues like skin offers a practical advantage for patient assessment.
Key Insights:
- Alpha-synuclein expression induction observed in skin fibroblasts.
- Potential for objective Parkinson's disease diagnosis using peripheral tissue biomarkers.
- Findings align with systems biology principles for understanding PD pathogenesis.
Outlook:
- Further validation of skin fibroblast biomarkers for PD diagnosis is warranted.
- Integration of functional genomics into systems biology can advance PD research.
- Clinical significance lies in developing accessible diagnostic tools for Parkinson's disease.
Related Concept Videos
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...